Adam's Secret Extra Strength 1500, 800 mg, 10 count blister packs, Distributed by KP Inc., Made in USA, UPC 6 09728 43462 5
Published March 31, 2021 · Recall initiated: February 15, 2021
Summary
FDA records drug Class I recall D-0310-2021, published March 31, 2021 and initiated February 15, 2021. Recalling firm: Adams.Secret.co; Status: Terminated; Reported quantity: 218 boxes; Lot: All lots within expiry. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Adams.Secret.co
- Distributor
- Nationwide in the USA
- Lot
- All lots within expiry.
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOmeprazole Delayed Release Capsules, USP, 20 mg, 1000-count bottles, Rx only, Packaged by GSMS Incorporated,March 31, 2021
- FDA0.9% SODIUM CHLORIDE Irrigation, USP 1000 mL Semi-Rigid Bottle, Rx only, Manufactured for ICU Medical, Inc.,March 31, 2021
- FDAQuseo Fresco sold under the following brands and container sizes - El Abuelito Cheese Brand - Queso FrescoMarch 31, 2021
- FDACyberKnife Treatment Delivery System - Product Usage: indicated for image-guided stereotactic radiosurgery andMarch 24, 2021
- FDAVITROS SARS-CoV-2 Antigen Reagent Pack - The VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reagent PackMarch 24, 2021
- FDAJUDKINS PACKMarch 24, 2021
Questions about this recall
Was Adam's Secret Extra Strength 1500, 800 mg, 10 count blister packs, Distributed by KP Inc., Made in USA, UPC 6 09728 43462 5 recalled?
Yes. FDA published recall D-0310-2021 on March 31, 2021. Reported hazard: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release